Thalidomide survivors to be given medical cards by Govt.

by Samantha Reed - Chief Editor
0 comments

Irish Government Outlines Support Measures for Thalidomide Survivors, Including Medical Cards

The Irish Government today announced a series of measures to support thalidomide survivors, including the provision of discretionary medical cards, in a meeting with representatives of the Irish Thalidomide Association (ITA) at Government Buildings in Dublin.

Taoiseach Micheál Martin and Tánaiste Simon Harris met with members of the ITA and confirmed that a pathway for acknowledging injuries caused by the drug is nearing completion. Minister for Health Jennifer Carroll MacNeill has agreed to provide discretionary medical cards to those currently seeking, or intending to seek, acknowledgement as thalidomide survivors through the State process. This move addresses a long-standing need for accessible healthcare for individuals affected by the drug’s devastating side effects.

The Government also committed to an enhanced package of services for all thalidomide survivors, building on last year’s announcement of simplified access to healthcare, therapies, independent living supports, and annual health assessments. Finola Cassidy of the ITA stated that they received a “clear commitment” from the Taoiseach and Tánaiste, adding, “They’ve committed politically to taking responsibility for this process.” The resolution process, led by retired judge Paul Gilligan, has faced claims of stalling, prompting the call for today’s meeting. The tragedy of thalidomide continues to impact survivors decades after the drug was withdrawn from the market.

There are currently 40 survivors of thalidomide in Ireland. Donal Browne, brother of the late campaigner Jacqui Browne, also attended the meeting. Officials confirmed they will meet with the board of the resolution process next month as they continue to work towards a resolution for all survivors and consider a formal State apology, a key demand of the ITA.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy